CHRM3 and ovarian carcinoma: The data showed that compared with adjacent normal cases, LINC01722 was upregulated, whereas AC134312.1, AL133467.1, CHRM3-AS2, and LINC02207 were downregulated in ovarian carcinoma (Supplementary figure 1a).